Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000239

EVP, Chief Development Officer sold 57,900 shares at $65.24 ($3,777,668)

  • EVP, Chief Development Officer acquired 57,900 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Geary Richard S · EVP, Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-30 Exercise or conversion : show line 1 in the form 10b5-1 +57,900 $53.77 $3,113,283 137,557 D
2025-09-30 Sale : show line 2 in the form 10b5-1 −57,900 $65.24 $3,777,668 79,657 D
Open-market sales · 57,900 sh · avg $65.24 · $3,777,668

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-30 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −57,900 0 D
Loading xslF345X05/edgardoc.xml…